Brade DeBriere (@bdebriere) profile picture
Atlanta, GA
Joined November 2011
Photo by Brade DeBriere (@bdebriere)Photo by Brade DeBriere (@bdebriere)Photo by Brade DeBriere (@bdebriere)Photo by Brade DeBriere (@bdebriere)Photo by Brade DeBriere (@bdebriere)
The time for health equity is now. Actor and Artist Ice-T @FINALLEVEL is helping the IMF raise awareness of multiple myeloma in the Black Community this #BlackHistoryMonth Watch Now: youtu.be/UpZCpVMMphQ #IMFMPOWER @jmikhaelmd
3
8
526
This #BlackHistoryMonth, we are highlighting disparities in #myeloma care. Black Americans are twice as likely to develop myeloma but face barriers to care. Learn more & join the fight for equity: mmsm.link/4ahUTUK @jmikhaelmd
2
3
486
On Sept 18 don't miss our webinar on the timely diagnosis of myeloma in diverse populations! Learn about healthcare disparities and testing methods. Register here: buff.ly/3Z6gGev
1
74
Brade DeBriere retweeted
Mark your calendar to join this #webinar on September 18 at 12:00pm EDT! Click to Register! ➡️eu1.hubs.ly/H0bWPsT0 #sebia #sebiausa #myeloma #Freelightchain #FLC #diagnosis #patientcare
1
63
CONGRESS | #COMy2024 | @IrenemGhobrial @DanaFarber shares the strategies for smoldering myeloma risk stratification. Ghobrial discusses the challenges in defining HR-SMM, suggesting methods to further refine risk criteria, and emphasising the benefits of early intervention in SMM. #mmsm #myeloma #multiplemyeloma @COMyCongress
4
11
1,098
During my UTSW laboratory rotation, out of 100 people we surveyed on the hospital campus, only 3 knew what a Medical Technologist (MLS) was and only 1 understood what we do! I love the ending of this video...it says it all.
Every day and all through the night, #MedLab professionals work tirelessly #BehindEveryPatient. We perform millions of tests every year, analyzing samples to inform diagnosis and keep you and your loved ones safe.
1
2
8
473
Thank you for reminding me why I love laboratory medicine, clinical laboratories, and the people who run them. Happy International Biomedical Laboratory Science Day...and Lab Week :)
1
62
I started the EVIDENCE meta-analysis in 2009. After 15 yrs of work, I will present 4/12 at ODAC: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patients’ access to new drugs? #mmsm ⁦@theMMRF⁩ ⁦@IMFmyeloma⁩ youtube.com/live/pooME9gMaL0…
6
14
73
4,151
Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains - Read on degruyter.com/document/doi/1… @degruyter_brill
1
2
91
18.8% clinical specificity improvement of the new ELISA sFLC when differential is made in a multiracial hospital setting. This cohort made sense to compare against because Myeloma is not yet screened in the general population.
53
Brade DeBriere retweeted
Visit Sebia at ASH in San Diego, Booth #2455 to hear about M-inSight, our new serum-based MRD test for monitoring Multiple Myeloma. Schedule time with our team of experts to learn more about this new assay: bit.ly/3sTjX32 #ASH23 #sebia #minsight #multiplemyeloma
1
1
146
Dr. Ben Andress showed that Sebia FLC measurement has equivalent value in risk stratification of MGUS patients compared to FreeLite. @ACLPS_ @MayoClinicPath #aclps2023
1
4
232
“Simple algebraic equation” to increase specificity of sFLC tests without eGFR based stratification. I might need a refresher course :)
1
2
Some of Amgen’s best new technology in a cup at ASH22
2
We tested the Sebia free light chain assay performance in the established cutpoints for MM diagnosis (iFLCr of 100) and high-risk SMM in a cohort of SMM patients. The test performance is equivalent to the comparator/reference test. rdcu.be/cVI7q @BloodCancerJnl – at Minnesota, USA
2
20